tiprankstipranks
Calithera Bio (CALA)
OTHER OTC:CALA
US Market

Calithera Bio (CALA) Stock Price & Analysis

449 Followers

CALA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.50
Previous Close$0.02
Volume1.28K
Average Volume (3M)1.90K
Market Cap
$97.45K
Enterprise Value-$25.27M
Total Cash (Recent Filing)$25.50M
Total Debt (Recent Filing)$136.00K
Price to Earnings (P/E)>-0.1
Beta0.43
Nov 08, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-8.56
Shares Outstanding4,872,497
10 Day Avg. Volume850
30 Day Avg. Volume1,902
Standard Deviation2.23
R-Squared0.00002
Alpha0.18
Financial Highlights & Ratios
Price to Book (P/B)-0.05
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.63
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

CALA FAQ

What was Calithera Bio’s price range in the past 12 months?
Calithera Bio lowest stock price was $0.01 and its highest was $0.50 in the past 12 months.
    What is Calithera Bio’s market cap?
    Currently, no data Available
    When is Calithera Bio’s upcoming earnings report date?
    Calithera Bio’s upcoming earnings report date is Nov 08, 2023 which is 141 days ago.
      How were Calithera Bio’s earnings last quarter?
      Currently, no data Available
      Is Calithera Bio overvalued?
      According to Wall Street analysts Calithera Bio’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Calithera Bio pay dividends?
        Calithera Bio does not currently pay dividends.
        What is Calithera Bio’s EPS estimate?
        Calithera Bio’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Calithera Bio have?
        Calithera Bio has 4,872,497 shares outstanding.
          What happened to Calithera Bio’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Calithera Bio?
          Among the largest hedge funds holding Calithera Bio’s share is PRIMECAP Management Co. It holds Calithera Bio’s shares valued at N/A.
            ---

            Calithera Bio Stock Smart Score

            Company Description

            Calithera Bio

            Calithera Biosciences, Inc. engages in discovering and developing small molecule drugs that that target novel and critical metabolic pathway in tumor and cance-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Crispr Therapeutics AG
            Arrowhead Pharmaceuticals
            Adverum Biotechnologies
            Ascendis Pharma
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis